FridayAug 03, 2018 12:27 pm

CBDNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Releases Corporate Video Detailing Exclusive National Agreement with Natural Specialty Sales

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF) earlier this week signed an exclusive national agreement with Natural Specialty Sales (“NSS”), an Acosta company. Per the agreement, Phivida’s OKI brand of premium CBD products will be the exclusive CBD-infused beverage brand and health supplements products represented by NSS, giving the company access to over 2,400 retail locations in a $4.1 billion market. The OKI line is anticipated to launch during the third quarter of 2018. "Obviously, there's been a lot of hard work behind the scenes. We've been working on this agreement for months, and to see it come to fruition today…

Continue Reading

FridayAug 03, 2018 9:21 am

CBDNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Changes Company Name to VIVO Cannabis™

Leading Canadian cannabis company ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) recently announced that it is changing its name to VIVO Cannabis Inc. to reflect the company’s evolution, purpose and direction. Effective at market open on Tuesday, August 7, 2018, the company will begin trading under it’s new ticker symbol “VIVO” on the TSX Venture Exchange. “ABcann was an early leader in the burgeoning cannabis industry. As a Licensed Producer since 2014, we have the experience, the knowledge and the people to create and deliver superior products,” VIVO Cannabis CEO Barry Fishman stated in the news release. “As VIVO Cannabis,…

Continue Reading

ThursdayAug 02, 2018 10:31 am

CBDNewsBreaks – Global Payout, Inc. (GOHE) Highlights Recent Performance of MTrac Platform

Global Payout, Inc. (OTC: GOHE) this morning announced that its MTrac Platform is on track to transact more than $600,000 in the coming weeks, and the company expects this number to “increase significantly as new merchants are onboarded.” The MTrac Platform was officially launched in June of this year, and Global Payout has since implemented six merchants that are currently active. Per the update, the company currently has more than 15 applications in various stages of implementation to further bolster the platform moving forward. “This is a very exciting time for all of us here at MTrac,” Vanessa Luna, CEO…

Continue Reading

ThursdayAug 02, 2018 10:22 am

CBDNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Engages NetworkNewsWire for Corporate Communications Solutions

Cannabis Strategic Ventures (OTC: NUGS) this morning announced that it has engaged the corporate communications expertise of NetworkNewsWire (“NNW”). Cannabis Strategic Ventures is a multidimensional company with a primary focus on supporting entrepreneurial growth within the burgeoning legal cannabis market through a carefully chosen portfolio of subsidiaries. As part of the Client-Partner relationship with Cannabis Strategic Ventures, NNW will employ its investor-based distribution network of over 5,000 key syndication outlets, numerous newsletters, social media channels, blogs and other outreach tools to generate greater brand awareness for the company. To view the full press release, visit http://cnw.fm/zoy0J About Cannabis Strategic Ventures,…

Continue Reading

ThursdayAug 02, 2018 10:00 am

CBDNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Posts Record Date for Spinout Transaction

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTC: TGODF) this morning issued an update regarding its previously announced spinout transaction. The company will distribute a warrant in the new corporation, TGOD Acquisitions, to TGOD shareholders. Each warrant permits the holder to purchase a unit of TGOD Acquisitions at a price of $0.50 for a period of 30 days from completion of the spinout. Each unit is comprised of one common share and one additional warrant of TGOD Acquisitions. The record date for distribution of the warrants is anticipated to be on or about September 28,…

Continue Reading

ThursdayAug 02, 2018 9:48 am

CBDNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Adds Third Entry to Lineup of Cannabis Brands

Leading Canadian cannabis company ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced the launch of Lumina, an adult-use cannabis brand and product line designed with health and wellness in mind. Per the update, Lumina supports a holistic approach to mental and physical well-being, which ABcann highlights as a key consideration in the flourishing wellness sector. “Lumina is the third entry in ABcann’s growing lineup of cannabis brands, joining Beacon Medical and FIRESIDE in our premium portfolio,” Barry Fishman, CEO of ABcann, stated in the news release. “Our extensive experience growing premium cannabis, emphasis on quality, and dedication to…

Continue Reading

ThursdayAug 02, 2018 9:23 am

CBDNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Enters Exclusive Co-marketing and Distribution Agreement

Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has entered into a definitive co-marketing and distribution agreement with S.T.U. GmbH. The Switzerland-based company manufactures and markets "Hemplix™" brand CBD oils. Per the terms of the agreement, Pivot's proprietary cannabinoid-derived products will be marketed and sold by S.T.U. online and in retail stores, where regulations permit, in the U.K., Switzerland, Germany, Austria and Italy. Pivot will distribute the Hemplix™ product line where regulations permit, and upon receiving required licenses from regulatory authorities, in Canada, Latin America and the United States. "As we continue to execute on…

Continue Reading

WednesdayAug 01, 2018 10:01 am

CBDNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Inks Exclusive National Agreement with Natural Specialty Sales

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF) this morning announced that it has signed an exclusive national agreement with Natural Specialty Sales (“NSS”), an Acosta company. NSS is well known in the natural/specialty market with a retail channel across America, providing Phivida access to over 2,400 retail locations in a $4.1 billion market. The national network includes major retailers including Whole Foods Market, Sprouts Farmers Market, and National Coop Grocers. The company’s OKI brand of premium CBD products, anticipated to launch in Q3 2018, will be the exclusive CBD-infused beverage brand and health supplements products represented by NSS. "There is no…

Continue Reading

WednesdayAug 01, 2018 9:30 am

CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Reports Encouraging Bioavailability Results from TurboCBD™ Study

Drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) this morning reported noteworthy bioavailability results from its randomized, placebo-controlled, double-blind European human clinical study that evaluated TurboCBD™. TurboCBD™ is a proprietary, DehydraTECH™ powered, cannabidiol ("CBD") fortified hemp oil capsule developed by Lexaria. The study evaluated the degree and speed of CBD absorption into blood plasma and potential cardiovascular and cognitive performance enhancement in 12 healthy male volunteers. The study compared the 90 mg dose of Lexaria's TurboCBD™ to a 90 mg dose of a positive control formulation without Lexaria's DehydraTECH™ technology. Per the report, Lexaria's TurboCBD™ capsules continued to…

Continue Reading

TuesdayJul 31, 2018 1:33 pm

CBDNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Posts Update on Scorpion Venom-Derived Peptide Program

PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) today issued an update regarding the second phase of its three phase, scorpion venom-derived peptide research and development program. The program consists of identifying, extracting and sequencing peptides and proteins isolated from Caribbean Blue Scorpion venom. The goal of the program is to empower PreveCeutical to produce Nature Identical™ peptide therapeutics to treat, regulate and prevent cancer progression. The company’s initial focus will target glioblastoma, a highly-aggressive form of brain cancer. PreveCeutical has started phase 2 of the program, comprised of re-designing the peptides to enhance their biostability while upholding their potency…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000